Health
Viral ‘molecular scissor’ is next COVID-19 drug target: Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins – Benzinga
SAN ANTONIO, Oct.18, 2020 /PRNewswire-PRWeb/ — American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel …
SAN ANTONIO, Oct.18, 2020 /PRNewswire-PRWeb/ — American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design blocking a molecular “scissor” that the virus uses for virus production and to disable human proteins crucial to the immune response.
The researchers are from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and the Wroclaw University of Science and Technology. Information glean…
-
General13 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year